Lucira Health Shares Up 341% After FDA Authorization as Company Seeks Strategic Partner
February 27 2023 - 10:12AM
Dow Jones News
By Dia Gill
Lucira Health Inc. shares soared 340.7% to 62 cents Monday
morning after the medical technology company announced it was
seeking a strategic partner to help resume manufacturing of its
recently approved Covid-19 & Flu test.
The company's stock more than doubled Friday after the Food and
Drug Administration issued emergency authorization of its Covid-19
& Flu test, the first at-home test able to detect the flu, and
the first test able to detect and differentiate between the flu and
Covid-19.
Just days ahead of the FDA's authorization, Lucira filed for
Chapter 11 bankruptcy. At the time, the company said it would
continue its operations during the bankruptcy process, while
seeking a sale of its business.
The company's stock is up 1.5% since the start of the year and
down 88% since one year ago.
Write to Dia Gill at dia.gill@wsj.com
(END) Dow Jones Newswires
February 27, 2023 09:57 ET (14:57 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Lucira Health (NASDAQ:LHDX)
Historical Stock Chart
From Jul 2023 to Jul 2024
